Cargando…
Aprotinin Attenuates the Elevation of Pulmonary Vascular Resistance After Cardiopulmonary Bypass
Pulmonary vascular resistance (PVR) is generally believed to be elevated after cardiopulmonary bypass (CPB) due to whole body inflammation. Aprotinin has an anti-inflammatory action, and it was hypothesized that aprotinin would attenuate the PVR increase induced by CPB. Ten mongrel dogs were placed...
Autores principales: | Yun, Tae-Jin, Rho, Joon-Ryang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733973/ https://www.ncbi.nlm.nih.gov/pubmed/16479060 http://dx.doi.org/10.3346/jkms.2006.21.1.25 |
Ejemplares similares
-
Aprotinin does not influence the inflammatory reaction to cardiopulmonary bypass in humans
por: Schmartz, D, et al.
Publicado: (1999) -
Preservation of renal endothelial integrity and reduction of renal edema by aprotinin does not preserve renal perfusion and function following experimental cardiopulmonary bypass
por: Dekker, Nicole A. M., et al.
Publicado: (2021) -
Low dose aprotinin increases mortality and morbidity in coronary artery bypass surgery
por: Aghadavoudi, Omid
Publicado: (2012) -
Low dose aprotinin increases mortality and morbidity in coronary artery bypass surgery(*)
por: Sabzi, Feridoun, et al.
Publicado: (2012) -
Effect of aprotinin on immunological resistance in tumour-bearing animals.
por: Latner, A. L., et al.
Publicado: (1976)